Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Intellia Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:NTLA | Benzinga

Q: What sector and industry does Intellia Therapeutics (NTLA) operate in?

Intellia Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Explore Intellia Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for NTLA.

Open	$7.94
Close	-
Volume / Avg.	1.64M / 3.45M
Day Range	$7.86 - $8.24
52 Wk Range	5.90 - 28.18
Market Cap	$844.18M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	54
Short Interest	29.57%
Days to Cover	7.78

Recent News

Wolverine World Wide, Pacira BioSciences And Other Big Stocks Moving Higher On Monday

Avi Kapoor

Cathie Wood's Ark Invest Continues To Offload UiPath, Roblox: Loads Up On GitLab, Ibotta

Ark Invest's Cathie Wood-led funds made significant trades involving GitLab, Intellia, Prime Medicine, UiPath, Ibotta, Roblox, Repare Therapeutics, and CareDx.

Rounak Jain

This RingCentral Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Jan

Feb

Mar

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.9

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$7.94
Close	-
Volume / Avg.	1.64M / 3.45M
Day Range	$7.86 - $8.24
52 Wk Range	5.90 - 28.18
Market Cap	$844.18M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	54
Short Interest	29.57%
Days to Cover	7.78

About Intellia Therapeutics Inc

Sector

Health Care

Industry

Biotechnology

Intellia Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based ther...

Got Questions? Ask

How is NTLA's EBITDA trending?

What are NTLA's Bollinger Band values?

What does NTLA's DCF valuation show?

What is NTLA's 7 days volume trend?

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Intellia Therapeutics (NTLA) stock?

You can purchase shares of Intellia Therapeutics (NASDAQ:NTLA) through any online brokerage.

View our list of the best stock brokerages

Who are Intellia Therapeutics (NTLA) competitors?

Other companies in Intellia Therapeutics’s space includes: Immunome (NASDAQ:IMNM), 89bio (NASDAQ:ETNB), Gyre Therapeutics (NASDAQ:GYRE), Syndax Pharmaceuticals (NASDAQ:SNDX) and CareDx (NASDAQ:CDNA).

What is the forecast, or price target, for Intellia Therapeutics (NTLA) stock?

Intellia Therapeutics has a consensus price target of $48.36.

What is the current price for Intellia Therapeutics (NTLA)?

The stock price for Intellia Therapeutics (NASDAQ: NTLA) is $8.155 last updated April 22, 2025 at 2:11 PM EDT.

Does Intellia Therapeutics (NTLA) pay a dividend?

There are no upcoming dividends for Intellia Therapeutics.

When is Intellia Therapeutics (NASDAQ:NTLA) reporting earnings?

Intellia Therapeutics’s Q1 earnings are confirmed for Thursday, May 8, 2025.

Is Intellia Therapeutics (NTLA) going to split?

There is no upcoming split for Intellia Therapeutics.

What sector and industry does Intellia Therapeutics (NTLA) operate in?

Intellia Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Intellia Therapeutics Stock Price, Quotes and Forecasts

Intellia Therapeutics (NTLA) Forecast